WO1993019749A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
JPH11509433A
(en)
|
1995-04-14 |
1999-08-24 |
グラクソ、ウェルカム、インコーポレーテッド |
Dosage inhaler for albuterol
|
DE19723722A1
(en)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nonsteroidal progestogens
|
TW533865U
(en)
|
1997-06-10 |
2003-05-21 |
Glaxo Group Ltd |
Dispenser for dispensing medicament and actuation indicating device
|
WO1999016766A1
(en)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Benzodioxole derivatives
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
PT1070056E
(en)
|
1998-03-14 |
2004-11-30 |
Altana Pharma Ag |
PDE III / IV INHIBITORS BASED ON FTALAZINONE
|
US6119853A
(en)
|
1998-12-18 |
2000-09-19 |
Glaxo Wellcome Inc. |
Method and package for storing a pressurized container containing a drug
|
US6315112B1
(en)
|
1998-12-18 |
2001-11-13 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6390291B1
(en)
|
1998-12-18 |
2002-05-21 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
CN1353717A
(en)
|
1999-05-04 |
2002-06-12 |
莱加制药公司 |
Tetracyclic progesterone receptor modulator compounds and methods
|
ES2165768B1
(en)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
|
CO5180649A1
(en)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
ANTAGONISTS OF GLUCOCORTICOID RECEPTORS FOR THE TREATMENT OF DIABETES FOR THE TREATMENT OF DIABETES
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
EA005992B1
(en)
|
2000-08-05 |
2005-08-25 |
Глаксо Груп Лимитед |
6alpha, 9alpha-DIFLUORO-17alpha-[(2-FURANYLCARBONYL)OXY]-11beta-HYDROXY-16alpha-METHYL-3-OXO-ANDROST-1,4-DIENE-17beta-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
AU2002253342B2
(en)
|
2001-04-30 |
2007-01-04 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
ES2307751T3
(en)
|
2001-06-12 |
2008-12-01 |
Glaxo Group Limited |
NEW CENTI-INFLAMMATORY HETEROCICLICAL ESTERS 17 ALPHA DERIVATIVES 17 ANDROSTANO CARBOTIOATE BETA.
|
ES2316599T3
(en)
|
2001-09-14 |
2009-04-16 |
Glaxo Group Limited |
DERIVATIVES OF PHENETANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES.
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
WO2003059899A1
(en)
|
2002-01-14 |
2003-07-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
AU2003214879B2
(en)
|
2002-01-22 |
2008-02-07 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
AU2003230700A1
(en)
|
2002-03-26 |
2003-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
UA80120C2
(en)
|
2002-03-26 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetics, pharmaceutical composition based thereon
|
DE10215316C1
(en)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Quinoline and isoquinoline derivatives, a pharmaceutical agent and their use as anti-inflammatory agents
|
DE60335869D1
(en)
|
2002-04-11 |
2011-03-10 |
Merck Sharp & Dohme |
1H-BENZO (F) INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
|
ES2298511T3
(en)
|
2002-04-25 |
2008-05-16 |
Glaxo Group Limited |
DERIVATIVES OF PHENETHANOLAMINE.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
MXPA05000345A
(en)
|
2002-07-08 |
2005-03-31 |
Pfizer Prod Inc |
Modulators of the glucocorticoid receptor.
|
PL375442A1
(en)
|
2002-07-18 |
2005-11-28 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
ES2331119T3
(en)
|
2002-09-16 |
2009-12-22 |
Glaxo Group Limited |
PIRAZOLO COMPOUNDS (3,4-B) PIRIDINE, AND ITS USE AS PHOSPHODESTERASE INHIBITORS.
|
AU2003270783C1
(en)
|
2002-09-20 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Octahydro-2-H-naphtho[1,2-F] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
US20060205790A1
(en)
|
2002-10-22 |
2006-09-14 |
Coe Diane M |
Medicinal arylethanolamine compounds
|
KR20050057681A
(en)
|
2002-10-28 |
2005-06-16 |
글락소 그룹 리미티드 |
Phenethanolamine derivative for the treatment of respiratory diseases
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
AP2007004239A0
(en)
|
2003-10-14 |
2007-12-31 |
Glaxo Group Ltd |
Muscarinic acetycholine receptor antagonists
|
BRPI0416128B8
(en)
|
2003-11-03 |
2021-06-22 |
Glaxo Group Ltd |
fluid dispensing device
|
PE20050489A1
(en)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS
|
US20070111995A1
(en)
|
2003-12-19 |
2007-05-17 |
Allen David G |
Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors
|
GB0405937D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
BRPI0508843A
(en)
|
2004-03-16 |
2007-08-28 |
Glaxo Group Ltd |
compound or salt thereof, method for preparing a compound or salt thereof, method of treatment and / or disease prophylaxis, and pharmaceutical composition
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
PE20060259A1
(en)
|
2004-04-27 |
2006-03-25 |
Glaxo Group Ltd |
QUINUCLIDINE COMPOUNDS AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
EP1805166B1
(en)
|
2004-10-19 |
2011-07-27 |
F. Hoffmann-La Roche AG |
Quinoline derivatives
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
WO2006072599A2
(en)
|
2005-01-10 |
2006-07-13 |
Glaxo Group Limited |
Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
EP2211615A4
(en)
*
|
2007-10-22 |
2010-10-13 |
Glaxosmithkline Llc |
Pyridosulfonamide derivatives as pi3 kinase inhibitors
|
EP2307400B1
(en)
*
|
2008-05-30 |
2014-04-23 |
Amgen, Inc |
Inhibitors of pi3 kinase
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|